Benzinga | Oct 29, 2021 10:48AM EDT

Novo Nordisk Sees FY21 Sales Growth 12%-15%

https://view.news.eu.nasdaq.com/view?id=befacb1bcc7fd7886532bc9bc60c96d08&lang=en